Evidence map›Paper›PMID 33291802›Full record

ArticleMolecules (Basel, Switzerland)2020

Synthesis, Characterization, and Antiproliferative Activity of Novel Chiral [QuinoxP*AuCl

Adedamola S Arojojoye, R Tyler Mertens, Samuel Ofori, Sean R Parkin, Samuel G Awuah

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Chiral gold(III) complexes: speciation,Chemical communications (Cambridge, England) · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adedamola S ArojojoyeDepartment of Chemistry, University of Kentucky, Lexington, KY 40506, USA.ORCID 0000-0003-3076-264X
R Tyler MertensDepartment of Chemistry, University of Kentucky, Lexington, KY 40506, USA.
Samuel OforiDepartment of Chemistry, University of Kentucky, Lexington, KY 40506, USA.ORCID 0000-0001-6921-9543
Sean R ParkinDepartment of Chemistry, University of Kentucky, Lexington, KY 40506, USA.ORCID 0000-0001-5777-3918
Samuel G AwuahDepartment of Chemistry, University of Kentucky, Lexington, KY 40506, USA.

Funding

Understanding the role of anti-apolipoprotein A-I antibodies in atherosclerotic cardiovascular diseaseP20GM130456 · NIGMS · UNIVERSITY OF KENTUCKY · PI Jon Scott Thorson · 2020 to 2026
$18.7M
NIGMS NIH HHS P20 GM130456
6 · The paper itself

Abstract

Herein is reported the synthesis of two Au(III) complexes bearing the (

Indexed as

Antineoplastic AgentsCell Line, TumorCell ProliferationCrystallography, X-RayGlutathioneGoldHumansLigandsStereoisomerismAntineoplastic AgentsGlutathioneGoldLigandsanticancer activityantiproliferativeauranofincisplatingoldligandsQuinoxP*

Identifiers

PMID33291802
PMCPMC7730091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.